Latest Breaking News On - Roberts negrin - Page 1 : comparemela.com

Orca-T Shows Feasibility as a Reduced-Intensity Transplant Strategy in Hematologic Malignancies

Robert S. Negrin, MD, discusses the use of Orca-T as a viable strategy for patients with hematologic malignancies undergoing allogeneic transplant.

Vice President of ASH Will Focus on Gene Therapies, ASH's Global Impact

The field of hematology is experiencing significant advancements as promising new therapies for malignancies and GVHD continue to emerge.

ASH elects three to leadership positions

02.23.23 -- Identifying Solutions To Today's Complex Study Challenges

02/23/23 Clinical Leader Newsletter

Appia Bio Names Scientific Advisory Board Member

Los Angeles-based biotechnology company Appia Bio said this morning that it has named Robert S. Negrin, M.D., to its Scientific Advisory Board. Dr. Negrin is a professor of medicine and former chief of th